FDA Adverse Event Malfunction Summary report: N

BRILLIANCE

MDR report key: 18585099 · Received January 25, 2024

Report

Report Number
3008581796-2024-00001
Event Type
Malfunction
Date Received
January 25, 2024
Date of Event
August 25, 2023
Manufacturer
PHILIPS MEDICAL SYSTEMS TECHNOLOGIES LTD.
Product Code
JAK
UDI-DI
00884838095168
PMA / PMN Number
K171850
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
RISK MANAGER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

NOTE: WE HAVE NOT COMPLETED OUR INVESTIGATION OF THIS EVENT. WE WILL FILE A FOLLOW-UP EMDR AT THE COMPLETION OF THE INVESTIGATION. INTERNAL CROSS REFERENCE: COMPLAINT (B)(4).

Additional Manufacturer Narrative · 0

THIS COMPLAINT HAS BEEN EVALUATED BASED ON THE INFORMATION PROVIDED; IT WAS REPORTED THAT THE CT SERIES RECONSTRUCTED WITH A X OR Y RECONSTRUCTION OFFSET PER DICOM PRIVATE TAG (01F1,100C), WHICH CAN BE USED WITHIN TUMOR LOC TO TRANSMIT INVALID ABSOLUTE MARKING COORDINATES TO A LASER MARKING SYSTEM. THIS ISSUE WAS IDENTIFIED DURING THE PHILIPS INTERNAL TESTING PROCESS WITHOUT PATIENT INVOVLEMENT. NO SIMILAR ISSUE HAS BEEN REPORTED BY THE CUSTOMER. PHILIPS HAS INVESTIGATED THIS COMPLAINT. ACCORDING TO THE INVESTIGATION RESULT, THIS ISSUE ONLY OCCURS WHEN THERE IS A RECON OFFSET IN X OR Y, IT WILL NOT OCCUR WHEN A RECON OFFSET IN BOTH X AND Y. THE CAUSE IS THAT A LOGIC ERROR WAS FOUND WITHIN THE TUMOR LOC CODEBASE, WHICH RESULTED IN TUMOR LOC BLOCKING ABSOLUTE MARKING FUNCTIONALITY FAILURE WHEN THERE WAS A RECON OFFSET IN EITHER X OR Y, BUT THE BLOCKING ABSOLUTE MARKING FUNCTIONALITY WORKED AS DESIGNED WHEN A RECON OFFSET IN BOTH X AND Y. THE INTENT OF BLOCKING ABSOLUTE MARKING FUNCTIONALITY WAS TO BLOCK ABSOLUTE MARKING WHEN A RECON OFFSET WAS PRESENT. THE CODE THAT COMPUTES ABSOLUTE MARKING COORDINATES DID NOT ACCOUNT FOR THE OFFSET IN EITHER X OR Y, BUT ONLY FOR THE OFFSET IN BOTH X AND Y, PRODUCING INCORRECT COORDINATES. THE SYSTEM WAS NOT IN CLINICAL USE WHEN THIS OCCURRED. A REVIEW OF THE RISK MANAGEMENT FILE INDICATES THE PROBLEM REPORTED BY THE CUSTOMER IS A LOW POTENTIAL SEVERITY WHICH WOULD NOT REASONABLY CAUSE OR CONTRIBUTE TO DEATH OR SERIOUS INJURY IF THE PROBLEM WERE TO REOCCUR. BASED ON THE INFORMATION AVAILABLE AND RESULTS OF ANALYSIS, NO FURTHER ACTION IS NECESSARY AT THIS TIME.

Description of Event or Problem · 0

THIS COMPLAINT HAS BEEN EVALUATED BASED ON THE INFORMATION PROVIDED; THERE IS NO ALLEGATION OF DEATH OR SERIOUS INJURY. IT WAS REPORTED THAT DURING THE PHILIPS INTERNAL TESTING PROCESS, IT WAS FOUND THAT THE CT SERIES RECONSTRUCTED WITH A X OR Y RECONSTRUCTION OFFSET PER DICOM PRIVATE TAG (01F1,100C), WHICH CAN BE USED WITHIN TUMOR LOC TO TRANSMIT INVALID ABSOLUTE MARKING COORDINATES TO A LASER MARKING SYSTEM. THESE INVALID COORDINATES MIGHT RESULT IN AN INCORRECT TREATMENT LOCATION ON THE PATIENT¿S SKIN. BASED ON THE AVAILABLE INFORMATION, THIS ISSUE HAS BEEN DETERMINED TO BE A REPORTABLE EVENT. PHILIPS HAS STARTED THE INVESTIGATION OF THIS EVENT.

Description of Event or Problem · 0

THIS COMPLAINT HAS BEEN EVALUATED BASED ON THE INFORMATION PROVIDED; THERE IS NO ALLEGATION OF DEATH OR SERIOUS INJURY. IT WAS REPORTED THAT DURING THE PHILIPS INTERNAL TESTING PROCESS, IT WAS FOUND THAT THE CT SERIES RECONSTRUCTED WITH A X OR Y RECONSTRUCTION OFFSET PER DICOM PRIVATE TAG (01F1,100C), WHICH CAN BE USED WITHIN TUMOR LOC TO TRANSMIT INVALID ABSOLUTE MARKING COORDINATES TO A LASER MARKING SYSTEM. THESE INVALID COORDINATES MIGHT RESULT IN AN INCORRECT TREATMENT LOCATION ON THE PATIENT¿S SKIN. BASED ON THE AVAILABLE INFORMATION, THIS ISSUE HAS BEEN DETERMINED TO BE A REPORTABLE EVENT. PHILIPS HAS NOW COMPLETED THE INVESTIGATION OF THIS COMPLAINT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1016535 BRILLIANCE COMPUTED TOMOGRAPHY X-RAY SYSTEM JAK PHILIPS MEDICAL SYSTEMS TECHNOLOGIES LTD. BIG BORE RT 00884838095168

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown